Effectiveness of tacrolimus ointment on facial lesions refractory to topical corticosteroid in patients with atopic dermatitis receiving dupilumab
Abstract Dupilumab demonstrated high efficacy and tolerable safety profiles in moderate‐to‐severe atopic dermatitis (AD) patients in clinical trials; however, certain patients suffer from facial redness, while obtaining good responses on the trunk and limbs to dupilumab in the real‐world setting. In...
Saved in:
Main Authors: | Hideaki Uchida (Author), Masahiro Kamata (Author), Shota Egawa (Author), Mayumi Nagata (Author), Saki Fukaya (Author), Kotaro Hayashi (Author), Atsuko Fukuyasu (Author), Takamitsu Tanaka (Author), Takeko Ishikawa (Author), Takamitsu Ohnishi (Author), Yayoi Tada (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
by: Hideaki Uchida, et al.
Published: (2021) -
Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report
by: Hideaki Uchida, et al.
Published: (2019) -
Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases
by: Makoto Ito, et al.
Published: (2023) -
Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis
by: Makoto Ito, et al.
Published: (2023) -
Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report
by: Saki Fukaya, et al.
Published: (2019)